James D. (“J.D.”) Myers ‘03 has been named associate director for policy at the U.S. Food and Drug Administration’s (FDA’s) Center for Biologics Evaluation and Research (CBER).  CBER regulates biological products for human use, with oversight of vaccines, cell and gene therapies, and blood. In this role, Myers is responsible for CBER’s overall policy activities and directs policies involving the regulation of CBER-regulated products, including those involving clinical trials, pre-and post-market approval issues, counterterrorism, emerging infectious diseases, legislative matters, and novel and emerging technologies.